Birdwatch Note
2024-08-01 19:09:45 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
L’adversaire est une boxeuse algérienne Imane Khelif qui est biologiquement une femme, possédant donc les chromosomes XX. Elle est atteinte d'hyperandrogénie, une condition qui touche 5 à 10 % des femmes et entraîne un taux de testostérone élevé. https://fr.wikipedia.org/wiki/Imane_Khelif https://fr.wikipedia.org/wiki/Hyperandrog%C3%A9nie
Written by 8EDCCA2886FD9715E5ADED45EF3F0E6820F169A4C715CC71D0B049AFEB0192C7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819085377023697297
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819088146396860843
- noteId - 1819088146396860843
- participantId -
- noteAuthorParticipantId - 8EDCCA2886FD9715E5ADED45EF3F0E6820F169A4C715CC71D0B049AFEB0192C7 Participant Details
- createdAtMillis - 1722539385781
- tweetId - 1819085377023697297
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- L’adversaire est une boxeuse algérienne Imane Khelif qui est biologiquement une femme, possédant donc les chromosomes XX. Elle est atteinte d'hyperandrogénie, une condition qui touche 5 à 10 % des femmes et entraîne un taux de testostérone élevé. https://fr.wikipedia.org/wiki/Imane_Khelif https://fr.wikipedia.org/wiki/Hyperandrog%C3%A9nie
Note Ratings
rated at | rated by | |
2024-08-11 05:23:59 -0500 | Rating Details | |
2024-08-05 05:33:03 -0500 | Rating Details | |
2024-08-03 08:26:42 -0500 | Rating Details | |
2024-08-02 11:12:17 -0500 | Rating Details | |
2024-08-02 07:41:17 -0500 | Rating Details | |
2024-08-02 07:37:36 -0500 | Rating Details | |
2024-08-02 04:16:27 -0500 | Rating Details | |
2024-08-02 02:18:58 -0500 | Rating Details | |
2024-08-02 02:14:06 -0500 | Rating Details | |
2024-08-01 21:42:25 -0500 | Rating Details | |
2024-08-01 21:40:52 -0500 | Rating Details | |
2024-08-01 18:11:44 -0500 | Rating Details | |
2024-08-01 18:07:54 -0500 | Rating Details | |
2024-08-01 17:58:07 -0500 | Rating Details | |
2024-08-01 17:53:42 -0500 | Rating Details | |
2024-08-01 17:49:15 -0500 | Rating Details | |
2024-08-01 15:59:50 -0500 | Rating Details | |
2024-08-01 15:57:27 -0500 | Rating Details | |
2024-08-01 15:44:39 -0500 | Rating Details | |
2024-08-01 15:30:49 -0500 | Rating Details | |
2024-08-01 15:23:44 -0500 | Rating Details | |
2024-08-01 15:04:47 -0500 | Rating Details | |
2024-08-01 15:02:50 -0500 | Rating Details | |
2024-08-01 15:00:54 -0500 | Rating Details | |
2024-08-01 14:59:43 -0500 | Rating Details | |
2024-08-01 14:59:22 -0500 | Rating Details | |
2024-08-01 14:54:14 -0500 | Rating Details | |
2024-08-01 14:49:41 -0500 | Rating Details | |
2024-08-01 14:45:47 -0500 | Rating Details | |
2024-08-01 14:38:00 -0500 | Rating Details | |
2024-08-01 14:37:25 -0500 | Rating Details | |
2024-08-01 14:36:55 -0500 | Rating Details | |
2024-08-01 14:34:56 -0500 | Rating Details | |
2024-08-01 14:33:38 -0500 | Rating Details | |
2024-08-01 14:32:55 -0500 | Rating Details | |
2024-08-01 14:29:24 -0500 | Rating Details | |
2024-08-01 14:25:10 -0500 | Rating Details | |
2024-08-01 14:24:10 -0500 | Rating Details | |
2024-08-01 14:23:52 -0500 | Rating Details | |
2024-08-01 14:23:16 -0500 | Rating Details | |
2024-08-01 14:21:22 -0500 | Rating Details | |
2024-08-01 14:15:02 -0500 | Rating Details | |
2024-08-04 00:36:34 -0500 | Rating Details | |
2024-08-02 07:42:11 -0500 | Rating Details |